KingMed Diagnostics released its 2026 semi-annual report, achieving attributable net profit of approximately 190 million yuan in the first half, up 324.27% year on year. The company's operating revenue for the same period was approximately 2.884 billion yuan, down 3.76% year on year. KingMed Diagnostics said it continued to advance cost reduction, efficiency improvement, and digital-intelligent transformation. The gross margin for the reporting period was 36.71%, up 2.78 percentage points year on year.
Guangzhou Kingmed Diagnostics Group Co LtdAttributable net profit surged 324.27% YoY, with improved gross margin, indicating strong earnings performance.
